Test my supply
+1 more ↓
71%
Finnrick rating
#185 of 301 ranked vendors
34 of 43 classifiable tests passed
methodology · Purity focus
Finnrick analysis

Atomik Labz's purity-focus record is strongest on Retatrutide, GHK-Cu and Tirzepatide, where identity and purity clear consistently, though several fills run high. The weaker side is dispersed: BPC-157 has repeated purity misses, CJC-1295 and Ipamorelin rebound after misses, and many results are narrow single-batch snapshots.

methodology →
vendor intelligence report
Vendor Intelligence Report: Atomik Labz

Wayback footers, Florida registry negatives, and live legal-page scrubbing trace Atomik Labz from changing JE Production names to no named counterparty. The report maps Solution Peptides and Warrior Peptides links, affiliate/referral rails, payment infrastructure, and batch-specific complaints.

29 pages7 risk factors assessed2 Jul 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
GHK-Cu
$0.55
90%
4
2
Retatrutide
$5.50
85%
8
3
Tirzepatide
$13.00
83%
5
4
Semaglutide
$13.00
75%
4
5
Melanotan II
$2.90
71%
4
6
Ipamorelin
$5.80
67%
5
7
PT-141
$3.70
58%
4
8
BPC-157
$6.00
46%
4
9
CJC-1295
$6.60
37%
5
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%5 May 2025: 40%5 May 2025: 43%5 May 2025: 45%6 May 2025: 50%6 May 2025: 54%6 May 2025: 62%6 May 2025: 63%6 May 2025: 63%6 May 2025: 64%6 May 2025: 64%6 May 2025: 64%6 May 2025: 64%6 May 2025: 65%6 May 2025: 64%6 May 2025: 65%6 May 2025: 65%6 May 2025: 65%7 May 2025: 62%7 May 2025: 62%7 May 2025: 62%7 May 2025: 62%7 May 2025: 62%7 May 2025: 62%8 May 2025: 61%8 May 2025: 62%20 May 2025: 61%20 May 2025: 61%20 May 2025: 61%20 May 2025: 60%21 May 2025: 61%21 May 2025: 62%21 May 2025: 62%21 May 2025: 63%25 Sept 2025: 63%25 Sept 2025: 64%4 Mar 2026: 66%4 Mar 2026: 66%11 May 2026: 67%12 Jun 2026: 67%3 Aug 2026: 69%10 Aug 2026: current 71%40%66%71%May 25Aug 26
Test my supply
Atomik Labz test history
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
3 Aug 2026Pass
Tirzepatide
lab nameView COA
12 Jun 2026Pass
Retatrutide
lab nameView COA
11 May 2026Pass
Retatrutide
lab nameView COA
4 Mar 2026Pass
Retatrutide
lab nameView COA
4 Mar 2026Pass
Retatrutide
lab nameView COA
25 Sep 2025Pass
CJC-1295 (No DAC)
lab nameView COA
25 Sep 2025Pass
Ipamorelin
lab nameView COA
21 May 2025Pass
PT-141
lab nameView COA
21 May 2025Pass
Melanotan II
lab nameView COA
21 May 2025Pass
Melanotan II
lab nameView COA
1-10 of 43

About Atomik Labz test results from Finnrick

Atomik Labz is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 9 peptides and 43 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Atomik Labz peptides in this dataset are Melanotan II (4 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 43 recent tests.

Corrections
No corrections.
Test my supply